The EHA Congress is the largest hematology event in Europe, bringing together professionals, researchers, and stakeholders from across the field.
The 2025 edition was held in Milan, Italy, from June 12 to 15. ERN-EuroBloodNet had a strong presence at the event, featuring a dedicated booth, active participation in several oral and poster sessions, and the organization of the ERN-EuroBloodNet Board of Network (BoN) meeting.
On 3 October 2023, the 24 ERN Coordinators, ePAGs representing their ERN on the EURORDIS, ePAGs Steering Committee (Loris Brunetta & Jacqueline Dubow for the ERN-EuroBloodNet), and EURORDIS co-signed an Open Letter calling on EU institutions and national governments to stand by European Reference Networks.
Discover the Open Letter together with the Press Release from EURORDIS!
The Viewpoint summarizes the role of ERN-EuroBloodNet to improve the overall approach and management of Sickle cell disease patients in EU through key actions developed by the network. The manuscript is the result of the joint work within 12 EU Member States, a total of 26 ERN-EuroBloodNet health professionals and patients representatives have contributed.
The Clinical Patient Management System (CPMS) is currently used by 122 ERN-EuroBloodNet users across 18 EU countries. 52 Panels have been opened so far in the platform from which 22 are closed, and 30 are still open for additional contributions. If you want to be part of this project, we recommend you to have a look at our website section where dedicated guides have been recently updated!
All 24 European Reference Networks (ERNs) has launched a dedicated website and social media campaign to collect information to help health professionals to find support for Ukrainian patients with rare diseases: diagnosis, treatment, advice. Please don't hesitate to contacting us for rare haematological patients in need of highly specialized diagnosis or treatment for their rare disease: coordination@eurobloodnet.eu
Keep informed about the latest information on Rare Hematological Diseases!
The latest insights from the EURORDIS Rare Barometer survey be presented during a webinar on 18 June 2026.
Next week, ERN-EuroBloodNet will once again participate in the European Hematology Congress 2026.
The World Orphan Drug Congress Europe will take place 26-28 October, 2026 in Amsterdam.
The European Commission has launched the 2026 Call for Affiliated Partners within the European Reference Networks (ERNs)
Dr María del Mar Mañú Pereira, Scientific Coordinatior of the ERN-EuroBloodNet, will be participating on the Closing pleanry
📊Real-world evidence is a cornerstone for rare diseases, from the pre-clinical research to the patient’s follow up at clinical units.
— ERN EuroBloodNet (@ERNEuroBloodNet) Jun 12, 2026
María del Mar Mañú Pereira and David-Zacharie Issom showcased how registries and the use of #AI can drive innovation, knowledge generation.
🏥 Strong national infrastructures are fundamental to strong European networks.
— ERN EuroBloodNet (@ERNEuroBloodNet) Jun 12, 2026
Raffaella Colombatti shared insights on how coordinated national systems can improve care, expertise and sustainability for rare disease patients.
#EHA2026 #ERNs #Networks
📢Connecting national and European efforts is essential to improve patient care. Béatrice Gulbis (ERN-EuroBloodNet Co-Coordinator, Belgium) highlighted lessons learned from the Belgian rare disease ecosystem and opportunities for greater integration across Europe.
— ERN EuroBloodNet (@ERNEuroBloodNet) Jun 12, 2026
#EHA2026 #ERNs
📢 Europe has a unique opportunity to lead innovation in rare diseases. Pierre FENAUX and Eduard J. van Beers explored how clinical trials, collaboration and equitable access can accelerate the delivery of innovative therapies to patients.
— ERN EuroBloodNet (@ERNEuroBloodNet) Jun 12, 2026
#Biotech #EHA2026 #ERNs #RD
Keep updated on the breaking news in the field of Rare Hematological Diseases and with the main achievements of ERN-EuroBloodNet!
Suscribe!